CEMPRA INC's ticker is CEMP and the CUSIP is 15130J109.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $592,000 | -36.9% | 182,000 | -10.8% | 0.00% | -50.0% |
| Q2 2017 | $938,000 | +12.6% | 204,000 | -8.1% | 0.01% | +20.0% |
| Q1 2017 | $833,000 | +31.6% | 222,000 | -1.8% | 0.01% | +25.0% |
| Q4 2016 | $633,000 | -89.6% | 226,000 | -10.1% | 0.00% | -88.9% |
| Q3 2016 | $6,084,000 | +45.0% | 251,400 | -1.2% | 0.04% | +44.0% |
| Q2 2016 | $4,195,000 | +71.0% | 254,400 | +81.7% | 0.02% | +66.7% |
| Q1 2016 | $2,453,000 | -15.7% | 140,000 | +49.7% | 0.02% | -16.7% |
| Q4 2015 | $2,911,000 | +33.9% | 93,509 | +19.7% | 0.02% | +38.5% |
| Q3 2015 | $2,174,000 | +5.4% | 78,100 | +30.2% | 0.01% | +18.2% |
| Q2 2015 | $2,062,000 | -3.1% | 60,000 | -3.2% | 0.01% | 0.0% |
| Q1 2015 | $2,127,000 | +29.2% | 62,000 | -11.4% | 0.01% | +37.5% |
| Q4 2014 | $1,646,000 | +109.9% | 70,000 | -2.1% | 0.01% | +100.0% |
| Q3 2014 | $784,000 | +152.1% | 71,500 | +146.6% | 0.00% | +100.0% |
| Q2 2014 | $311,000 | – | 29,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital LLC | 2,193,060 | $68,270,000 | 11.77% |
| Abingworth LLP | 383,935 | $11,948,000 | 7.21% |
| ACUTA CAPITAL PARTNERS, LLC | 250,000 | $7,783,000 | 3.72% |
| Opaleye Management Inc. | 200,000 | $6,226,000 | 2.60% |
| Knoll Capital Management, LLC | 180,800 | $5,628,000 | 2.09% |
| Palo Alto Investors LP | 1,175,733 | $36,601,000 | 2.04% |
| BB BIOTECH AG | 1,991,900 | $62,008,000 | 1.75% |
| AlpInvest Partners B.V. | 31,400 | $977,000 | 1.62% |
| GENERAL AMERICAN INVESTORS CO INC | 494,409 | $15,391,000 | 1.41% |
| HARVEY CAPITAL MANAGEMENT INC | 112,250 | $3,494,000 | 1.38% |